Predictions
Merck KGaA
Start price
Target price
Perf. (%)
€184.15
09.08.21
09.08.21
-
09.08.22
09.08.22
-1.52%
26.03.22
26.03.22
ROE higher than 10% per year
Low dividend yield expected
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.015
20.02.22
20.02.22
€7.50
20.03.22
20.03.22
61900.00%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.74
20.02.22
20.02.22
€30.00
20.03.22
20.03.22
2.76%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€3.04
20.02.22
20.02.22
€4.00
20.03.22
20.03.22
-11.39%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€81.03
15.03.22
15.03.22
-
15.03.23
15.03.23
-14.84%
20.03.22
20.03.22
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€13.20
06.03.22
06.03.22
-
06.03.23
06.03.23
17.35%
17.03.22
17.03.22
Risky Investment
Novocure Ltd
Start price
Target price
Perf. (%)
€59.26
09.01.22
09.01.22
€51.00
09.01.23
09.01.23
8.34%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€20.53
14.03.22
14.03.22
€14.00
14.03.23
14.03.23
3.70%
16.03.22
16.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€30.25
13.10.21
13.10.21
€34.00
30.07.22
30.07.22
-32.13%
14.03.22
14.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.39
30.01.22
30.01.22
€4.00
30.01.23
30.01.23
-10.83%
14.03.22
14.03.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.00
13.10.21
13.10.21
-
13.10.22
13.10.22
24.89%
13.03.22
13.03.22
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.00
13.10.21
13.10.21
-
13.10.22
13.10.22
24.89%
13.03.22
13.03.22
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.00
13.10.21
13.10.21
-
13.10.22
13.10.22
24.89%
13.03.22
13.03.22
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€4.66
12.07.21
12.07.21
-
12.07.22
12.07.22
48.95%
13.03.22
13.03.22
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€18.30
09.02.22
09.02.22
€20.00
09.03.22
09.03.22
-7.10%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year